Form 4 for SPRY ARS Pharmaceuticals, Inc.
Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-05 · accession 0001415889-25-007438 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-07 | 2025-03-05+ | SPRY | Shawver Laura | Dir | M - OptEx | $4.85 | +50.0K | 259.9K | +24% | +$242.5K |
| DM | 2025-03-07 | 2025-03-05+ | SPRY | Shawver Laura | Dir | S - Sale+OE | $11.21 | -50.0K | 210.3K | -19% | -$560.4K |
| DM | 2025-03-07 | 2025-03-05+ | SPRY | Shawver Laura | Dir | M - OptEx | $0.00 | -50.0K | 123.7K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-05 | M | A | 400 | $4.85 | 210,746 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-06 | S | D | 49,600 | $11.21 | 210,346 | D | — | — | (F2) The weighted average sale price for the transaction reported was $11.2106 and the range of prices were between $11.00 and $11.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Common | Common Stock | 2025-03-06 | M | A | 49,600 | $4.85 | 259,946 | D | — | — | |
| 4 | Common | Common Stock | 2025-03-05 | S | D | 400 | $11.00 | 210,346 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-03-06 | M | D | 49,600 | $0.00 | 74,064 | D | $4.85 · — to 2032-01-31 | 49,600 Common Stock | (F3) Immediately exercisable. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-03-05 | M | D | 400 | $0.00 | 123,664 | D | $4.85 · — to 2032-01-31 | 400 Common Stock | (F3) Immediately exercisable. |